Scrip
Expect FDA transparency recommendations on NDA/BLA disclosures early next year
05 November 2009
Sue Sutter
Please Login to read the full article.
05 November 2009
Sue Sutter
The US FDA's transparency task force expects to release draft recommendations in early 2010 on the types of medical product application information that should be disclosed by the agency and under what circumstances.
Speaking to
Scrip after the task force's second public...
Please Login to read the full article.
RELATED CONTENT
NEWS
- FDA transparency group urges expanded disclosures on pending NDAs
- US FDA task force to weigh disclosure of complete response letters
- US FDA senior staff appointments reflect consumer advocacy and regulatory expertise
- US FDA plans expanded conflict-of-interest disclosures for advisory panels
ANALYSIS
- Executive Briefing - Battle lines drawn over parallel trade
- Executive Briefing – Brazil emerges as a saviour for pharma
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
